Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Chinese Patent Office
Argus Health
Farmers Insurance

Generated: August 17, 2017

DrugPatentWatch Database Preview

TENUATE Drug Profile

« Back to Dashboard

Which patents cover Tenuate, and when can generic versions of Tenuate launch?

Tenuate is a drug marketed by Actavis Labs Ut Inc and Sanofi Aventis Us and is included in four NDAs.

The generic ingredient in TENUATE is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.

Summary for Tradename: TENUATE

Suppliers / Packagers: see list9
Bulk Api Vendors: see list36
Patent Applications: see list2,141
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TENUATE at DailyMed

Pharmacology for Tradename: TENUATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut Inc
diethylpropion hydrochloride
TABLET;ORAL011722-002Approved Prior to Jan 1, 1982AARXYesYes► Subscribe► Subscribe► Subscribe
Actavis Labs Ut Inc
diethylpropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL012546-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
diethylpropion hydrochloride
TABLET;ORAL017668-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Sanofi Aventis Us
diethylpropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL017669-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Cantor Fitzgerald
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus